Medicare Enrolled
Dr. William Robison, M.D.
Internal Medicine · Wichita Falls, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Robison from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Robison?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Robison
Dr. William Robison is an internal medicine specialist in Wichita Falls, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Robison performed 8,544 Medicare services across 5,629 unique beneficiaries.
Between the years covered by Open Payments, Dr. Robison received a total of $15,253 from 54 pharmaceutical and/or device companies across 1036 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Robison is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in TX
$15,253 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,544
Medicare services
Top 4% in TX for internal medicine
5,629
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~427 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,007 | $83 | $255 |
| Blood draw (venipuncture) | 870 | $8 | $16 |
| Complete blood count (CBC) with differential | 479 | $8 | $27 |
| Prothrombin time test (blood clotting) | 463 | $4 | $27 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 439 | $15 | $54 |
| Urine microalbumin test (kidney screening) | 372 | $6 | $40 |
| Office visit, established patient (20-29 min) | 367 | $62 | $169 |
| Comprehensive metabolic blood panel | 363 | $10 | $74 |
| Annual wellness visit, follow-up | 348 | $123 | $130 |
| Thyroid stimulating hormone (TSH) test | 319 | $16 | $111 |
| Lipid panel (cholesterol and triglycerides) | 310 | $13 | $86 |
| Hemoglobin A1c test (diabetes monitoring) | 290 | $9 | $67 |
| Annual alcohol misuse screening, 5 to 15 minutes | 235 | $17 | $50 |
| Annual depression screening | 218 | $17 | $38 |
| Flu vaccine administration | 182 | $29 | $35 |
| Flu vaccine, high-dose | 179 | $71 | $138 |
| Dexamethasone injection (steroid) | 162 | $0 | $2 |
| Basic metabolic blood panel | 148 | $8 | $58 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 145 | $18 | $66 |
| Vitamin D level test | 124 | $28 | $199 |
| Urinalysis with microscopic exam | 123 | $3 | $8 |
| Prostate cancer screening; prostate specific antigen test (psa) | 111 | $18 | $118 |
| Detection test by immunoassay with direct visual observation for influenza virus | 89 | $16 | $81 |
| Automated urinalysis | 70 | $2 | $16 |
| Sed rate test (inflammation marker) | 67 | $3 | $18 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 61 | $32 | $122 |
| Ceftriaxone antibiotic injection | 60 | $0 | $22 |
| Complete blood count (CBC), automated | 57 | $6 | $54 |
| Telephone medical discussion with physician, 11-20 minutes | 55 | $66 | $160 |
| Iron level test | 52 | $6 | $44 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 52 | $41 | $87 |
| Iron binding capacity test | 50 | $9 | $58 |
| Vitamin B-12 level test | 46 | $15 | $103 |
| Office visit, established patient (10-19 min) | 46 | $36 | $104 |
| Office visit, established patient, complex (40-54 min) | 46 | $129 | $346 |
| Drug injection, under skin or into muscle | 43 | $9 | $54 |
| Free thyroxine (T4) test | 42 | $9 | $61 |
| Liver enzyme (sgpt), level | 42 | $5 | $36 |
| Microscopic examination for white blood cells with manual cell count | 42 | $4 | $24 |
| Creatine kinase (cardiac enzyme) level, total | 36 | $6 | $45 |
| Uric acid level test | 35 | $4 | $33 |
| Electrocardiogram (EKG), 12-lead | 33 | $10 | $50 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 31 | $140 | $357 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 31 | $16 | $81 |
| C-reactive protein test (inflammation marker) | 30 | $5 | $34 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 29 | $39 | $162 |
| Amylase (enzyme) level | 24 | $6 | $45 |
| Calcium level, total | 20 | $5 | $36 |
| Blood potassium level | 19 | $5 | $33 |
| Blood creatinine level | 17 | $5 | $36 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 15 | $159 | $279 |
| Urea nitrogen level to assess kidney function, quantitative | 14 | $4 | $26 |
| Rheumatoid factor analysis | 14 | $6 | $40 |
| Pneumococcal vaccine, 23-valent | 11 | $131 | $232 |
| Pneumonia vaccine administration | 11 | $30 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,253
Total received (2018-2024)
Avg $2,179/year across 7 years
Top 6% in TX for internal medicine
54
Companies
1,036
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,124 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$129 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,615
2023
$2,432
2022
$1,782
2021
$1,764
2020
$2,021
2019
$2,190
2018
$2,449
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$2,297
AstraZeneca Pharmaceuticals LP
$1,956
Lilly USA, LLC
$1,563
SANOFI-AVENTIS U.S. LLC
$1,027
Boehringer Ingelheim Pharmaceuticals, Inc.
$935
GlaxoSmithKline, LLC.
$876
PFIZER INC.
$791
Amgen Inc.
$774
Amarin Pharma Inc.
$500
Merck Sharp & Dohme Corporation
$426
Janssen Pharmaceuticals, Inc
$416
Currax Pharmaceuticals LLC
$388
Corcept Therapeutics
$353
Bayer Healthcare Pharmaceuticals Inc.
$342
Novartis Pharmaceuticals Corporation
$331
Lundbeck LLC
$183
Dexcom, Inc.
$170
ABBVIE INC.
$130
Bayer HealthCare Pharmaceuticals Inc.
$124
Takeda Pharmaceuticals U.S.A., Inc.
$106
Astellas Pharma US Inc
$104
Exact Sciences Corporation
$103
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$101
Eisai Inc.
$90
Biohaven Pharmaceutical Holding Company Ltd.
$88
Allergan Inc.
$85
E.R. Squibb & Sons, L.L.C.
$77
Merck Sharp & Dohme LLC
$72
AbbVie Inc.
$71
Ethicon US, LLC
$64
Allergan, Inc.
$58
Antares Pharma, Inc.
$54
Abbott Laboratories
$49
Synergy Pharmaceuticals Inc
$47
Xeris Pharmaceuticals, Inc.
$46
IDORSIA PHARMACEUTICALS US INC
$45
Genentech USA, Inc.
$45
IBSA Pharma Inc.
$44
Biogen, Inc.
$33
Biohaven Pharmaceuticals, Inc.
$29
Nalpropion Pharmaceuticals LLC
$29
Inspire Medical Systems, Inc.
$28
Circassia Pharmaceuticals Inc
$28
Esperion Therapeutics, Inc.
$26
Sumitomo Pharma America, Inc.
$19
Phathom Pharmaceuticals, Inc.
$18
Azurity Pharmaceuticals, Inc.
$18
Avanir Pharmaceuticals, Inc.
$16
Noden Pharma USA Inc
$15
Regeneron Healthcare Solutions, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$14
Orexigen Therapeutics, Inc.
$14
Nalpropion Pharmaceuticals, Inc.
$13
Horizon Therapeutics plc
$11
Top 3 companies account for 38.1% of total payments
Associated products mentioned in payments ›
ADUHELM · ADVAIR · AIRSUPRA · ANORO · ANORO ELLIPTA · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CHANTIX · COLOGUARD · COMIRNATY · CONTRAVE · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbyclor · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre · GARDASIL · GEMTESA · GVOKE PFS · Horizant · INSPIRE · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LINX Reflux Management System · LINZESS · LYRICA · Licart · MOUNJARO · MYRBETRIQ · Motegrity · NEXLETOL · NUEDEXTA · NURTEC ODT · OFEV · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PRALUENT · PREMARIN · PREVNAR - 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TEKTURNA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · TUDORZA PRESSAIR · TZIELD · Tirosint · Tresiba · Trulance · UBRELVY · Uloric · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · VYEPTI · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · Xultophy 100/3.6 · ZEPBOUND · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for internal medicine in TX.
Equivalent to $179 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
47
Per 100K population
36.2
County median income
$62,168
Nearest hospital
UNITED REGIONAL HEALTH CARE SYSTEM
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Robison is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), with low-engagement industry engagement in the top 6% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Robison experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Robison performed 1,007 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Robison receive payments from pharmaceutical companies?
Yes. Dr. Robison received a total of $15,253 from 54 companies across 1,036 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Robison's costs compare to other internal medicine physicians in Wichita Falls?
Dr. Robison's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Robison) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Wichita Falls
Browse internal medicine physicians in Wichita Falls ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology